| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 81, 1009-1013, Copyright © 1996 by Endocrine Society
ARTICLES |
L Marshall, M Molle, G Boschen, A Steiger, HL Fehm and J Born
Clinical Neuroendocrinology, Medical University of Lubeck, Federal Republic of Germany.
It has been suggested that growth hormone (GH)-releasing hormone (GHRH) stimulates the surge in GH and enhances slow-wave sleep (SWS), two phenomena that characterize the beginning of nocturnal sleep. However, in human studies the effects of systemic GHRH administration on sleep were not consistent. This may reflect the differential influence of administration procedures being episodic in one of the above studies, but either a continuous infusion or a single bolus in the others. The present study in healthy volunteers compared changes in nocturnal sleep following 200 micrograms GHRH administered iv either episodically (4 boluses of 50 micrograms each at 2200, 2300, 2400, and 0100 h) or as a continuous infusion (57 micrograms/h between 2130 and 0100 h). Time spent in stage 4 of SWS on nights of episodic GHRH administration significantly exceeded that on nights of continuous GHRH administration (P < 0.01). Compared with a placebo condition, episodic administration of GHRH enhanced SWS (P < 0.01) and rapid eye movement (REM) sleep (P < 0.05) and diminished time spent in wakefulness and sleep stage 1 (P < 0.05). Effects of continuous GHRH infusion on sleep generally remained insignificant compared with placebo. Plasma GH concentrations were enhanced during both conditions of GHRH administration (P < 0.01), with the increase following episodic administration slightly exceeding that during continuous infusion (P < 0.05). The results support a greater physiological efficacy of episodic GHRH stimulation in promoting sleep.
This article has been cited by other articles:
![]() |
R. G. Smith, L. Betancourt, and Y. Sun Molecular Endocrinology and Physiology of the Aging Central Nervous System Endocr. Rev., April 1, 2005; 26(2): 203 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Snow, E. Gozal, A. Malhotra, D. Tiosano, R. Perlman, C. Vega, E. Shahar, D. Gozal, Z.'e. Hochberg, and G. Pillar Severe Hypersomnolence After Pituitary/Hypothalamic Surgery in Adolescents: Clinical Characteristics and Potential Mechanisms Pediatrics, December 1, 2002; 110(6): e74 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Spiegel, R. Leproult, E. F. Colecchia, M. L'Hermite-Baleriaux, Z. Nie, G. Copinschi, and E. Van Cauter Adaptation of the 24-h growth hormone profile to a state of sleep debt Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2000; 279(3): R874 - R883. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Blackman Age-Related Alterations in Sleep Quality and Neuroendocrine Function: Interrelationships and Implications JAMA, August 16, 2000; 284(7): 879 - 881. [Full Text] [PDF] |
||||
![]() |
M. Kimura, T. Kodama, M. C. Aguila, S.-Q. Zhang, and S. Inoue Granulocyte-Macrophage Colony-Stimulating Factor Modulates Rapid Eye Movement (REM) Sleep and Non-REM Sleep in Rats J. Neurosci., July 15, 2000; 20(14): 5544 - 5551. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Beranek, I. Hajdu, J. Gardi, P. Taishi, F. Obal Jr., and J. M. Krueger Central administration of the somatostatin analog octreotide induces captopril-insensitive sleep responses Am J Physiol Regulatory Integrative Comp Physiol, November 1, 1999; 277(5): R1297 - R1304. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gardi, F. Obal Jr., J. Fang, J. Zhang, and J. M. Krueger Diurnal variations and sleep deprivation-induced changes in rat hypothalamic GHRH and somatostatin contents Am J Physiol Regulatory Integrative Comp Physiol, November 1, 1999; 277(5): R1339 - R1344. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, F. Obal Jr, T. Zheng, J. Fang, P. Taishi, and J. M. Krueger Intrapreoptic Microinjection of GHRH or Its Antagonist Alters Sleep in Rats J. Neurosci., March 15, 1999; 19(6): 2187 - 2194. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Giustina and J. D. Veldhuis Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human Endocr. Rev., December 1, 1998; 19(6): 717 - 797. [Abstract] [Full Text] |
||||
![]() |
J. Zhang, Z. Chen, P. Taishi, F. Obal Jr., J. Fang, and J. M. Krueger Sleep deprivation increases rat hypothalamic growth hormone-releasing hormone mRNA Am J Physiol Regulatory Integrative Comp Physiol, December 1, 1998; 275(6): R1755 - R1761. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Moreno-Reyes, M. Kerkhofs, M. L'Hermite-Baleriaux, M. O. Thorner, E. Van Cauter, and G. Copinschi Evidence against a role for the growth hormone-releasing peptide axis in human slow-wave sleep regulation Am J Physiol Endocrinol Metab, May 1, 1998; 274(5): E779 - E784. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Beranek, F. Obal Jr., P. Taishi, B. Bodosi, F. Laczi, and J. M. Krueger Changes in rat sleep after single and repeated injections of the long-acting somatostatin analog octreotide Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1997; 273(4): R1484 - R1491. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Khorram, G. A. Laughlin, and S. S. C. Yen Endocrine and Metabolic Effects of Long-Term Administration of [Nle27]Growth Hormone-Releasing Hormone-(1-29)-NH2 in Age-Advanced Men and Women J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1472 - 1479. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |